Summary List PlacementSidra Capital, a Saudi asset management and private equity firm, purchased a suburban Philadelphia life sciences and healthcare campus in a recapitalization deal that valued the property at $225 million. Spear Street Capital, a real estate investment firm, will retain a 10% minority interest. The deal was brokered by JLL. The five-building, 855,600 square foot Arborcrest facility was completed in two phases, 2015 and 2019, and includes as tenants Signant Health, a clinical trial management company, Pharmaceutical Research Association, a clinical research organization, and Abington Memorial, an outpatient facility.